The Polycystic Kidney Disease (PKD) is a genetic disease which is characterized by the gradual emergence of cystic lesions in the kidneys, which replace the renal parenchyma causing deterioration of its function to stage 5. The PKD is one of the causes of Chronic Kidney Disease on renal replacement therapy (RRT). The Polycystic Kidney Disease has two patterns of inheritance: autosomal dominant pattern and the autosomal recessive pattern. The dominant form is more common but less severe than autosomal recessive form. PKD is known that is caused by mutations in several loci of the human genome. The autosomal dominant form can be caused by mutations in two different genes (PKD1 and PKD2), unlike the autosomal recessive form only has a causal gene (PKHD1). At present the international scientific community efforts toward deeper understanding of the pathophysiology of this entity for the purpose of developing therapeutic alternatives that avoid the appearance of cysts or progression of those already in place. The aim is to systematize the available scientific knowledge about Polycystic Kidney Disease and provide a source of consultation update on clinical characteristics and therapeutic options for patients with PKD.
CITATION STYLE
Rivero, P. C., Andrade, R. E. C., Baquero, S. M., & Espirel, V. M. (2016). Polycystic kidney disease. Bionatura. Centro de Biotecnologia y Biomedicina, Clinical Biotec. Universidad Católica del Oriente (UCO), Univesidad Yachay Tech. https://doi.org/10.21931/RB/2016.01.01.7
Mendeley helps you to discover research relevant for your work.